Xavier Bossuyt mainly focuses on Immunology, Antibody, Anti-nuclear antibody, Pathology and Autoantibody. His studies deal with areas such as Internal medicine, Inflammatory bowel disease and Ulcerative colitis as well as Immunology. His biological study spans a wide range of topics, including Gastroenterology and Vaccination.
In the field of Antibody, his study on Immunoglobulin G overlaps with subjects such as Gene expression profiling. His Anti-nuclear antibody research includes elements of IIf, Indirect immunofluorescence, Lupus erythematosus, Mixed connective tissue disease and Inflammatory myopathy. His study in Pathology is interdisciplinary in nature, drawing from both Evidence-based medicine and Clinical competence.
Xavier Bossuyt spends much of his time researching Immunology, Antibody, Internal medicine, Autoantibody and Pathology. His studies in Immunology integrate themes in fields like Anti-neutrophil cytoplasmic antibody and Inflammatory bowel disease. Xavier Bossuyt interconnects Molecular biology, Disease, Antigen and Microbiology in the investigation of issues within Antibody.
The Internal medicine study combines topics in areas such as Gastroenterology and Serology. He has included themes like Dermatomyositis and Myositis in his Autoantibody study. His Anti-nuclear antibody research incorporates themes from Lupus erythematosus and IIf, Indirect immunofluorescence.
The scientist’s investigation covers issues in Internal medicine, Immunology, Autoantibody, Anti-nuclear antibody and Indirect immunofluorescence. His Internal medicine research incorporates elements of Gastroenterology and Immunoassay. His research investigates the link between Immunology and topics such as Vasculitis that cross with problems in MEDLINE.
The concepts of his Autoantibody study are interwoven with issues in Dermatology, Dermatomyositis, Autoimmunity and Myositis. The various areas that Xavier Bossuyt examines in his Anti-nuclear antibody study include Mixed connective tissue disease and IIf. His studies deal with areas such as Pathology, Disease, Clinical significance and Significant difference as well as Antibody.
His primary areas of study are Immunology, Anti-nuclear antibody, Indirect immunofluorescence, Dermatology and Antibody. His work in Immunology addresses subjects such as Myositis, which are connected to disciplines such as Dermatomyositis. His studies in Anti-nuclear antibody integrate themes in fields like Immunofluorescence, IIf and Nuclear medicine.
His Indirect immunofluorescence study combines topics in areas such as Disease activity and Pathology. His research in Antibody is mostly focused on Idiopathic inflammatory myopathies. His biological study spans a wide range of topics, including Rheumatism, Internal medicine and Rheumatology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)
Pierre Quartier;Florence Allantaz;Rolando Cimaz;Pascal Pillet.
Annals of the Rheumatic Diseases (2011)
International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies
Nancy Agmon-Levin;Nancy Agmon-Levin;Jan Damoiseaux;Cornelis Kallenberg;Ulrich Sack.
Annals of the Rheumatic Diseases (2014)
Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease
Marc Peeters;Sofie Joossens;Severine Vermeire;Robert Vlietinck.
The American Journal of Gastroenterology (2001)
Selective predisposition to bacterial infections in IRAK-4–deficient children: IRAK-4–dependent TLRs are otherwise redundant in protective immunity
Cheng Lung Ku;Horst Von Bernuth;Horst Von Bernuth;Capucine Picard;Shen Ying Zhang.
Journal of Experimental Medicine (2007)
Clinical Features and Outcome of Patients With IRAK-4 and MyD88 Deficiency
Capucine Picard;Capucine Picard;Horst Von Bernuth;Horst Von Bernuth;Horst Von Bernuth;Pegah Ghandil;Pegah Ghandil;Pegah Ghandil;Maya Chrabieh;Maya Chrabieh.
The value of serologic markers in indeterminate colitis : a prospective follow-up study
Sofie Joossens;Walter Reinisch;Séverine Vermeire;Boualem Sendid.
Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn's disease: a prospective cohort study.
Severine Vermeire;Maja Noman;Gert Van Assche;Filip Baert.
Serologic Markers in Inflammatory Bowel Disease
Clinical Chemistry (2006)
Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis
Xavier Bossuyt;Jan Willem Cohen Tervaert;Yoshihiro Arimura;Daniel Blockmans.
Nature Reviews Rheumatology (2017)
Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: a study in IBD families.
Severine Vermeire;Marc Peeters;Robert Vlietinck;Sofie Joossens.
Inflammatory Bowel Diseases (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: